Gateshead's Shield Therapeutics posts first operating profit as US sales and licensing deals grow
Licensing income from China and Europe is now complementing direct sales growth in the US.
Sector
North East health and care news
Sector
Licensing income from China and Europe is now complementing direct sales growth in the US.